Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
8.08 USD | -2.42% | +4.94% | -67.48% |
Kurzporträt
Mitarbeiterzahl: 131
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Brian Wong
CEO | Chief Executive Officer | 52 | 01.08.15 |
Rodney Young
DFI | Director of Finance/CFO | 61 | 02.12.19 |
Jim Farmer
CTO | Chief Tech/Sci/R&D Officer | - | 04.05.22 |
William Ho
CTO | Chief Tech/Sci/R&D Officer | 58 | 01.05.15 |
Dirk Brockstedt
CTO | Chief Tech/Sci/R&D Officer | 55 | 01.01.18 |
Nipun Davar
CTO | Chief Tech/Sci/R&D Officer | - | 13.02. |
Investor Relations Contact | 63 | - | |
General Counsel | - | 03.05.23 | |
Adnan Rahman
PRN | Corporate Officer/Principal | - | 28.09.22 |
Shari L. Geffon
PRN | Corporate Officer/Principal | - | 04.05.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 04.12.19 |
William Rieflin
CHM | Chairman | 64 | 01.05.15 |
Wendye Robbins
BRD | Director/Board Member | 63 | 22.10.19 |
Brian Wong
CEO | Chief Executive Officer | 52 | 01.08.15 |
Michael Giordano
BRD | Director/Board Member | 66 | 01.01.18 |
Linda Kozick
BRD | Director/Board Member | 66 | 01.12.16 |
Director/Board Member | 46 | 09.11.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 34 799 702 | 32 017 440 ( 92,00 %) | 0 | 92,00 % |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-67.48% | 281 Mio. | |
+0.82% | 106 Mrd. | |
+8.38% | 23.47 Mrd. | |
-13.89% | 21.9 Mrd. | |
-6.22% | 18.77 Mrd. | |
-37.26% | 17.85 Mrd. | |
-10.98% | 16.78 Mrd. | |
+8.67% | 14.41 Mrd. | |
+41.08% | 12.86 Mrd. | |
+327.78% | 8.78 Mrd. |
- Börse
- Aktien
- A2PNYQ Aktie
- Unternehmen RAPT Therapeutics, Inc.